Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -200,403 | -166,637 | -101,826 | -48,397 | -177,119 |
| Depreciation Amortization | 2,379 | 1,853 | 1,325 | 661 | 2,328 |
| Accounts receivable | -2,463 | -1,885 | -1,610 | -516 | -982 |
| Accounts payable and accrued liabilities | 14,801 | 5,673 | -3,198 | -9,108 | 6,454 |
| Other Working Capital | 14,238 | 2,470 | -7,220 | -11,470 | 2,659 |
| Other Operating Activity | -7,332 | 1,237 | 8,859 | 13,700 | 4,763 |
| Operating Cash Flow | $-178,780 | $-157,289 | $-103,670 | $-55,130 | $-161,897 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,347 | -68,521 | -122,297 | -110,224 | -49,473 |
| PPE Investments | -1,031 | -557 | -250 | N/A | -470 |
| Investing Cash Flow | $-15,378 | $-69,078 | $-122,547 | $-110,224 | $-49,943 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 49,961 |
| Common Stock Issued | 64 | -1,641 | 89 | 88 | 138,823 |
| Common Stock Repurchased | -1,730 | N/A | -1,730 | -1,730 | -824 |
| Other Financing Activity | 240,015 | 240,094 | 241,010 | 241,025 | 0 |
| Financing Cash Flow | $238,349 | $238,453 | $239,369 | $239,383 | $187,960 |
| Beginning Cash Position | 22,465 | 22,465 | 22,465 | 22,465 | 46,345 |
| End Cash Position | 66,656 | 34,551 | 35,617 | 96,494 | 22,465 |
| Net Cash Flow | $44,191 | $12,086 | $13,152 | $74,029 | $-23,880 |
| Free Cash Flow | |||||
| Operating Cash Flow | -178,780 | -157,289 | -103,670 | -55,130 | -161,897 |
| Capital Expenditure | -1,031 | -557 | -250 | N/A | -470 |
| Free Cash Flow | -179,811 | -157,846 | -103,920 | -55,130 | -162,367 |